Breviscapine alleviates myocardial ischemia-reperfusion injury in diabetes rats.
Zhenhong SuYuanmei ZhengMeng HanDeqing ZhaoZhi HuangYijun ZhouWenbing HuPublished in: Acta cirurgica brasileira (2024)
For treating MIRI of diabetes in rats, the breviscapine can reduce the blood glucose and lipid levels, improve the cardiac function, reduce the myocardial injury, and decrease the inflammatory response and oxidative stress, thus exerting the alleviating effect.
Keyphrases
- blood glucose
- glycemic control
- inflammatory response
- type diabetes
- oxidative stress
- cardiovascular disease
- left ventricular
- weight loss
- insulin resistance
- dna damage
- ischemia reperfusion injury
- toll like receptor
- adipose tissue
- metabolic syndrome
- heart failure
- immune response
- diabetic rats
- atrial fibrillation
- induced apoptosis
- skeletal muscle